News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,981 Results
Type
Article (5033)
Company Profile (23)
Press Release (216925)
Section
Business (82319)
Career Advice (461)
Deals (15070)
Drug Delivery (8)
Drug Development (19192)
Employer Resources (30)
FDA (3688)
Job Trends (3919)
News (120388)
Policy (7521)
Tag
Academia (293)
Alliances (14744)
Alzheimer's disease (215)
Approvals (3683)
Bankruptcy (94)
Best Places to Work (2868)
Biotechnology (24)
Breast cancer (21)
Cancer (239)
Career advice (391)
Cell therapy (54)
Clinical research (15787)
Collaboration (83)
Compensation (65)
COVID-19 (294)
C-suite (46)
Data (286)
Diabetes (24)
Diagnostics (1998)
Earnings (40016)
Employer resources (31)
Events (37025)
Executive appointments (134)
FDA (3798)
Funding (91)
Gene therapy (25)
GLP-1 (98)
Government (407)
Healthcare (5004)
Infectious disease (305)
Inflammatory bowel disease (22)
Interviews (53)
IPO (7738)
Job creations (1123)
Job search strategy (360)
Layoffs (98)
Legal (2324)
Lung cancer (26)
Manufacturing (28)
Medical device (3819)
Medtech (3820)
Mergers & acquisitions (7370)
Metabolic disorders (74)
Neuroscience (260)
NextGen Class of 2024 (1675)
Non-profit (724)
Northern California (528)
Obesity (36)
Opinion (28)
People (24201)
Phase I (4714)
Phase II (6860)
Phase III (5449)
Pipeline (261)
Postmarket research (628)
Preclinical (1844)
Press Release (66)
Radiopharmaceuticals (104)
Rare diseases (37)
Real estate (1869)
Regulatory (5001)
Research institute (301)
Resumes & cover letters (68)
Southern California (401)
Startups (1012)
United States (4193)
Vaccines (25)
Date
Today (23)
Last 7 days (238)
Last 30 days (1274)
Last 365 days (11155)
2024 (10306)
2023 (13245)
2022 (18717)
2021 (19751)
2020 (18283)
2019 (13255)
2018 (10243)
2017 (10031)
2016 (9180)
2015 (12155)
2014 (9613)
2013 (7716)
2012 (8350)
2011 (8813)
2010 (8642)
Location
Africa (183)
Arizona (49)
Asia (11340)
Australia (1560)
California (1073)
Canada (451)
China (29)
Colorado (40)
Connecticut (54)
Europe (24149)
Florida (139)
Georgia (22)
Idaho (23)
Illinois (74)
Indiana (35)
Japan (31)
Kansas (23)
Maine (34)
Maryland (138)
Massachusetts (895)
Michigan (60)
Minnesota (98)
New Jersey (334)
New York (296)
North Carolina (239)
Northern California (528)
Ohio (36)
Pennsylvania (226)
South America (274)
Southern California (401)
Texas (124)
Utah (31)
Washington State (97)
221,981 Results for "sumitomo corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Sumitomo Corporation makes investment in Brazilian insect protein production and biotechnology company Cyns to Support Next Generation Sustainable Feed Production
Sumitomo Corporation, through Sumitomo Corporation do Brasil S.A. announced a joint investment in a Seed round for Cyns, a biotechnology company located in Sao Paulo, Brazil, to unlock the next chapter of black soldier fly farming in Latin America.
January 30, 2024
·
4 min read
Genetown
Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at the European Hematology Association (EHA) 2024 Hybrid Congress.
June 14, 2024
·
7 min read
Business
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Sumitomo Mitsui Banking Corporation announced that the three companies signed a master agreement on April 22, 2024, to establish a joint venture company.
April 22, 2024
·
5 min read
Drug Development
Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting
Sumitomo Pharma America, Inc., (SMPA) today announced the presentation of data from URO-901-3005, a Phase 3 randomized, double-blind, parallel-group, fixed-dose study evaluating the efficacy, safety, and tolerability of vibegron.
May 7, 2024
·
8 min read
Press Releases
Provident Healthcare Partners Advises Quest Health Solutions in its Partnership with Sumitomo Corporation of Americas
July 18, 2024
·
3 min read
Genetown
Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia
Sumitomo Pharma America, Inc. (SMPA), announced today the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for vibegron.
May 13, 2024
·
7 min read
Press Releases
Sumitomo Corporation of Americas Investment in Vast Medical Holdings; Marks Entry into U.S. Healthcare Market with Goals to Improve Patient Outcomes
July 18, 2024
·
4 min read
BioMidwest
Sumitomo Chemical and Valent BioSciences Announce Divestiture of Pace International and Future Collaboration with AgroFresh Solutions in the Postharvest Solutions Space
Sumitomo Chemical Co., Ltd. and Valent BioSciences LLC announced that Pace International LLC and its operations overseas will become part of AgroFresh Solutions, Inc., a well-established leader in the postharvest solutions space.
March 27, 2024
·
5 min read
Sumitomo Pharma Announces Availability of ORGOVYX® (relugolix) in Canada, the First and Only Oral Androgen Deprivation Therapy Treatment for Men with Advanced Prostate Cancer
Sumitomo Pharma Canada, Inc., announced that ORGOVYX®, an oral gonadotropin-releasing hormone receptor antagonist, is now available for prescription in Canada for the treatment of adult patients with advanced prostate cancer.
March 12, 2024
·
4 min read
Business
Sumitomo Cuts 62 Jobs in NYC Due to Company Consolidation
The layoffs are a result of Sumitomo’s decision announced in April to combine its seven subsidiaries into one company.
July 6, 2023
·
2 min read
·
Rosemary Scott
1 of 22,199
Next
